H

H1

469 employees

H1 provides a health data platform to support the end-to-end therapeutic development process of medical companies and healthcare systems.

Basic info

Industry

software development

Sectors

Biotechnology
medical science liaison
healthcare data
Life Science
kol mapping
biotechnology
clinical trials
healthcare professional information
data science
life sciences
Healthcare content
Healthcare
key opinion leaders
pharmaceutical
Pharmacuticals
clinical operations
msl education
kol
global drug development
msl
healthcare
healthcare content
AI
Health Care
Data Science
Medical Affairs
HCPs
medical device
Therapeutics
medical affairs
SaaS
diversity data
medtech sales
Medical
provider data

Date founded

2017

Funding rounds raised

Total raised

$100M

from 26 investors over 26 rounds

H

H1 raised $23M on June 9, 2022

Investors: Novartis Japan, Goldman Sachs Asset Management, Menlo Ventures and Leerink Transformation Partners

H

H1 raised $100M on November 16, 2021

Investors: Altimeter, Lux Capital, IVP, Menlo Ventures, Flex Capital, dRx data, Lead Edge Capital, Goldman Sachs Asset Management and Leerink Transformation Partners

H

H1 raised $58M on December 17, 2020

Investors: Y Combinator, Leerink Transformation Partners, IVP, Lead Edge Capital, dRx data, Lux Capital and Menlo Ventures

H

H1 raised $13M on March 22, 2020

Investors: ClearPoint Investment Partners, Liquid 2 Ventures, Y Combinator, dRx data and Menlo Ventures

H

H1 raised undisclosed on January 30, 2020

Investors: Y Combinator

FAQ